“…As indicated in a recent study, radiation oncology specialty is a top offender for exceeding the sustainable growth rate (SGR) target, with its excess expenditures from 2003 to 2009 hovering at 300% range as compared to 2002 [8]. To mitigate negative impact of Medicare cuts on cancer patents and radiation oncology specialty, big data can be exploited to improve treatment efficacy, optimize therapeutic ratio as well as personalize treatment options [9,10]. Finally, patient data generated within radiation oncology practices is currently residing in separated silos, and has so far not translated into some actionable insights into the best ways of treating patients who are the source of these data.…”